♟️ Friday 23 January 2026 Fri, 23 Jan 2026

Jindalee Lithium has secured US government approval for its McDermitt Lithium Project’s exploration plan, reported strong drilling results, and extended exclusivity on a US SPAC listing valued at US$500 million.

Global Lithium Resources has released a strong Definitive Feasibility Study for its Manna Lithium Project, confirming its economic resilience, while also initiating an IPO to spin out its Marble Bar gold assets.

Ioneer Ltd has reported a significant uplift in the economics of its Rhyolite Ridge lithium-boron project, alongside ongoing strategic partnership talks and strong market demand for lithium and boric acid.

Resolution Minerals is fast-tracking development of the historic Golden Gate Tungsten Mine in Idaho, leveraging expert geological insight and acquiring a nearby processing mill and stockpiles amid soaring tungsten prices.

Novo Resources has responded to an ASX price query, attributing recent share price and volume spikes to insider buying and rising gold prices, while confirming no undisclosed material information.

Cycliq Group Ltd reported a 21% decline in customer receipts for Q2 FY2026, offset by a solid net operating cash inflow and a strong Black Friday campaign that generated $1.3 million in gross revenue.

Insignia Financial has responded to ASX concerns over past disclosures of performance rights, affirming shareholder approvals and outlining improved compliance measures.

Echo IQ has completed clinical validation of its EchoSolv HF heart failure detection software with the Mayo Clinic Platform, achieving outstanding accuracy. The company has now formally submitted its FDA 510(k) clearance application, positioning itself for significant commercial expansion in the US healthcare market.

Dateline Resources has bolstered its financial position with a $35 million institutional placement, setting the stage for expanded drilling and a strategic transition to U.S. reporting standards at its Colosseum Gold-REE Project in California.

Cyprium Metals is advancing its brownfield restart of the Nifty Copper Complex in Western Australia, targeting mid-2026 copper cathode production with a low-capital, high-cash-flow approach. The company has secured $41 million through an institutional placement and entitlement offer to fund exploration and expansion.

Cyprium Metals has raised A$41 million through an oversubscribed equity placement and entitlement offer to accelerate exploration and production growth at its flagship Nifty Copper Complex and regional projects.

West Wits Mining has transitioned its Qala Shallows project from mobilisation to underground production, delivering first ore to surface and targeting its first gold pour in March 2026. The company has secured substantial funding to support this milestone and future growth.

WiseTech Global has announced its key financial and governance dates for FY26, highlighting its ongoing commitment to innovation and global logistics software dominance.

King River Resources advances exploration with new drill and soil sampling results at Tennant Creek, revealing promising IOCG-style mineralisation corridors and appointing a new Managing Director.

Rhythm Biosciences has begun commercialising its blood-based colorectal cancer test, ColoSTAT®, following key accreditations and validation. The company also secured a strategic partnership with NHS England and expanded its geneType™ platform globally.

Celsius Resources has released a Definitive Feasibility Study for its Maalinao-Caigutan-Biyog (MCB) Copper-Gold Project, confirming robust economics and a 35-year mine life. The study highlights strong returns, low operating costs, and a clear path to development in the Philippines.

Anteris Technologies Global Corp. has entered a material definitive agreement to raise approximately $320 million through a public offering and a strategic private placement with Medtronic’s subsidiary. The capital will support clinical trials and manufacturing expansion for its innovative heart valve technology.

Euroz Hartleys reports a striking 121% jump in net profit for H1 FY2026, driven by booming equity capital markets activity and rising advisory fees. The company also lifts its interim dividend, signalling confidence amid cyclical market conditions.

Falcon Metals has reported compelling high-grade gold results from its Blue Moon project in Victoria, extending mineralisation along strike and confirming the potential for a significant new gold reef. The company also advances exploration at Pyramid Hill and Errabiddy while maintaining a strong cash position.

Sky Metals has launched a major drilling campaign at its Tallebung Tin Project, aiming to expand high-grade resources and update its Mineral Resource Estimate. Meanwhile, a metallurgical breakthrough at Doradilla confirms its potential as a second key tin asset.

Nyrada Inc. has secured ethics approval to launch a Phase IIa clinical trial for its heart attack drug Xolatryp®, with patient recruitment set for March 2026. The company maintains a solid cash position of AU$7.12 million as it expands its research into oncology.

Arovella Therapeutics has filed an IND application for its lead CAR-iNKT therapy ALA-101, selected a CRO for its upcoming phase 1 trial, and secured $19.4 million in cash to fund clinical progress and pipeline expansion.

Bounty Oil & Gas has announced a significant board renewal, including the appointment of Kane Marshall as Chairman and the retirement of long-serving CEO Philip Kelso. These leadership changes mark a new chapter as the company pursues growth in its Australian oil and gas assets.

American Tungsten & Antimony Ltd is progressing its Nasdaq listing plans with a confidential SEC filing expected in March 2026 and has appointed Deutsche Bank as ADR depositary alongside a new CFO to support growth.